Juvena Therapeutics | $33,500,000 | (Jan 14, 2026)
bricks.sh | $1,863,303 | (Jan 14, 2026)
Allos | $5,000,000 | (Jan 14, 2026)
Susu
France
- Lyon, Rhone-Alpes
- 02/03/2022
- Pre-Seed
- $1,000,000
Susu's mission is to make healthcare affordable and accessible for Africans, in an integrated approach which connects the beneficiaries of the services, their families, and healthcare professionals.
- Our services include care bundles which are packages of curative and preventative services designed to monitor the condition of chronic disease patients and pregnant women.
- We also offer insurance services in partnership with insurance providers.
- Our offers can be subscribed by African diaspora members on behalf of their loved ones back home
- Industry Hospital & Health Care
- Website https://www.susu.fr/
- LinkedIn https://www.linkedin.com/company/susufrance/
Related People
Bola BardetFounder
Switzerland -
Givrins, Vaud
Executive MBA graduate from HEC Paris, I founded an insurtech/medtech startup dedicated to improving the quality of life for African through healthcare.
Passionate about entrepreneurship ie bringing to life solutions from A to Z, solving problems on a daily basis, and witnessing how on the short and long run it impacts our customers lives.
Incurable optimist, dreamer, resilient, strong learning appetite, and to-do list killer ;)
Philosophy, psychology, fashion and tennis lover.
Specialties: insurtech, medtech, product design, business process & service design, business development, B2C & B2B sales management, digital marketing, e-commerce, financial analysis, compliance.
Chartered Financial Analyst (CFA®) and Project Management Professional (PMP®)
PayMedix | $33,000,000 | (Jan 14, 2026)
WeatherPromise | $12,800,000 | (Jan 14, 2026)
Diffraqtion | $4,200,000 | (Jan 14, 2026)
WithCoverage | $42,000,000 | (Jan 14, 2026)
Nodu | $1,450,000 | (Jan 14, 2026)
Cloudforce | $10,000,000 | (Jan 14, 2026)
Converge Bio | $25,000,000 | (Jan 14, 2026)
JetZero | $175,000,000 | (Jan 14, 2026)
TRYBE | $30,000,000 | (Jan 13, 2026)